首页> 外文期刊>Therapeutic Drug Monitoring >Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee
【24h】

Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee

机译:确保临床实践中免疫抑制药物浓度的测量程序具有适当的分析性能:国际治疗药物监测和临床毒理学协会免疫抑制药物科学委员会的建议

获取原文
获取原文并翻译 | 示例
           

摘要

Monitoring immunosuppressive drugs (ISDs) in blood or plasma is still a key therapeutic drug monitoring (TDM) application in clinical settings. Narrow target ranges and severe side effects at drug underexposure or overexposure make accurate and precise measurements a must. This overview prepared by the Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology is intended to serve as a summary and guidance document describing the current state-of-the-art in the TDM of ISDs.
机译:监测血液或血浆中的免疫抑制药物(ISD)仍然是临床环境中关键的治疗药物监测(TDM)应用。狭窄的靶标范围和药物暴露不足或过度暴露所带来的严重副作用使得必须进行精确的测量。由国际治疗药物监测和临床毒理学协会的免疫抑制药物科学委员会编写的概述旨在作为概述和指导文件,描述ISD TDM中的最新技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号